Study suggests weight-loss drugs may curb impulsivity linked to violent crime

Daniel Semenza of Rutgers University reported that people presently on GLP-1 medications exhibit markedly lower impulsivity and alcohol consumption, both recognized risk factors for violence. The research suggests the drugs modulate brain regions governing reward and self-control, which may blunt the conversion of urges into aggressive actions. Roughly 15% of American adults have used GLP-1 drugs like Ozempic or Wegovy, meaning a sizable portion of the population could be experiencing these effects.

While the study does not establish a direct causal relationship between GLP-1 use and reduced violent crime, it highlights a possible ancillary benefit of the medications. The broader drop in U.S. violent crime also reflects younger demographic shrinkage, reduced substance use after pandemic peaks, and increased police use of AI tools such as Palantir’s Gotham. Semenza emphasizes the need for longitudinal research to confirm any long-term impact on crime rates.